Our results also, for the first time, demonstrate the impacts of BM-MSC exosomes on AML by revealing that these exosomes can decrease the expression levels of MALAT1, HOTAIR, and H19 lncRNAs, which are all involved in AML development and poor prognosis. The gene discussed is MALAT1; the disease is acute myeloid leukemia.